Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

411 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of Lianhua Qingwen capsules combined with standard of care in the treatment of adult patients with mild to moderate COVID-19 (FLOSAN): protocol for a randomized, double-blind, international multicenter clinical trial.
Zhan YQ, Chen RF, Zheng QS, Li XW, Liu YN, Mootsikapun P, Chayakulkeeree M, Arttawejkul P, Lan TTN, Liu GG, Lu HZ, Liu QQ, Zhong NS, Yang ZF, Zheng JP. Zhan YQ, et al. Among authors: liu gg, liu qq, liu yn. J Thorac Dis. 2023 May 30;15(5):2859-2872. doi: 10.21037/jtd-23-281. Epub 2023 Apr 23. J Thorac Dis. 2023. PMID: 37324081 Free PMC article.
Oseltamivir compared with the Chinese traditional therapy maxingshigan-yinqiaosan in the treatment of H1N1 influenza: a randomized trial.
Wang C, Cao B, Liu QQ, Zou ZQ, Liang ZA, Gu L, Dong JP, Liang LR, Li XW, Hu K, He XS, Sun YH, An Y, Yang T, Cao ZX, Guo YM, Wen XM, Wang YG, Liu YL, Jiang LD. Wang C, et al. Among authors: liu qq, liu yl. Ann Intern Med. 2011 Aug 16;155(4):217-25. doi: 10.7326/0003-4819-155-4-201108160-00005. Ann Intern Med. 2011. PMID: 21844547 Clinical Trial.
Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: A multicenter, prospective, randomized controlled trial.
Hu K, Guan WJ, Bi Y, Zhang W, Li L, Zhang B, Liu Q, Song Y, Li X, Duan Z, Zheng Q, Yang Z, Liang J, Han M, Ruan L, Wu C, Zhang Y, Jia ZH, Zhong NS. Hu K, et al. Phytomedicine. 2021 May;85:153242. doi: 10.1016/j.phymed.2020.153242. Epub 2020 May 16. Phytomedicine. 2021. PMID: 33867046 Free PMC article. Clinical Trial.
Efficacy and Safety of Lianhuaqingwen Capsules, a repurposed Chinese Herb, in Patients with Coronavirus disease 2019: A multicenter, prospective, randomized controlled trial [Phytomedicine 85 (2021) 153242].
Hu K, Guan WJ, Bi Y, Zhang W, Li L, Zhang B, Liu Q, Song Y, Li X, Duan Z, Zheng Q, Yang Z, Liang J, Han M, Ruan L, Wu C, Zhang Y, Jia ZH, Zhong NS. Hu K, et al. Phytomedicine. 2021 Dec;93:153775. doi: 10.1016/j.phymed.2021.153775. Epub 2021 Oct 17. Phytomedicine. 2021. PMID: 34670161 No abstract available.
Efficacy and safety of Lianhua Qingwen capsules, a repurposed Chinese herb, in patients with Coronavirus disease 2019: A multicenter, prospective, randomized controlled trial [Phytomedicine 85 (2021) 153242].
Hu K, Guan WJ, Bi Y, Zhang W, Li L, Zhang B, Liu Q, Song Y, Li X, Duan Z, Zheng Q, Yang Z, Liang J, Han M, Ruan L, Wu C, Zhang Y, Jia ZH, Zhong NS. Hu K, et al. Phytomedicine. 2022 Jan;94:153800. doi: 10.1016/j.phymed.2021.153800. Epub 2021 Oct 9. Phytomedicine. 2022. PMID: 34775361 Free PMC article. No abstract available.
[Thoughts on path of R&D and registration of innovative traditional Chinese medicine with synchronous transformation of "series prescriptions"].
Ai YL, Tang JY, Zhou G, Zhang L, Qu LP, Huang SY, Yang ZQ, Yuan WA, Zhou YH, Wang T, Zhao JN, Sun XB, Xiao XH, Yang ZF, Liu QQ, Zhu MJ, Leng XY, Xie CG, Chai SY. Ai YL, et al. Among authors: liu qq. Zhongguo Zhong Yao Za Zhi. 2022 Feb;47(4):1120-1125. doi: 10.19540/j.cnki.cjcmm.20211027.501. Zhongguo Zhong Yao Za Zhi. 2022. PMID: 35285213 Chinese.
411 results